Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study.
Saved in:
| Title: | Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study. |
|---|---|
| Authors: | Zhen J; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China., Liu S; Department of Neurology, Shenzhen Longhua District Central Hospital, Shenzhen, China., Liu L; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China., Zheng X; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China., Zhao G; CAS Key Laboratory of Human-Machine Intelligence-Synergy Systems, Research Center for Neural Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Liang J; 'Precision Health Research Center Company Limited, Hong Kong SAR, China., Xu A; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Li C; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China.; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China., Ren L; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China., Wu J; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China., Cheung BMY; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.; Institute of Cardiovascular Science and Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. |
| Source: | Annals of medicine [Ann Med] 2025 Dec; Vol. 57 (1), pp. 2500689. Date of Electronic Publication: 2025 May 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2060 (Electronic) Linking ISSN: 07853890 NLM ISO Abbreviation: Ann Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2060 |
|---|---|
| DOI: | 10.1080/07853890.2025.2500689 |
